Search ELMD
Electromed, Inc.
NYSE · CIK 1488917
Last close28.1
Daily change-0.40 (-1.40%)
10 Years gain+504.30%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
ELMD · STANDARD
SIC 3845 · Electromedical & Electrotherapeutic Apparatus · Fiscal year end 0630
Fundamental
81.4Momentum
63.7Acceleration
77.6Confidence
100.0Annual Revenue16
Quarterly Revenue50
Annual CFO13
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth16.3 / 25
Quality19.4 / 25
Capital Efficiency19.9 / 20
Balance Sheet15.0 / 15
Shareholder Economics6.6 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 1.3409 percentage points.
Operating leverageOperating margin improved by 2.7344 percentage points.
ROIC expansionROIC improved by 9.6909 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Share count reductionDiluted share count declined 3.4127%.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Warnings
FCF deterioration · MEDIUMFree cash flow declined 20.2009%.
High SBC · MEDIUMStock based compensation is high relative to revenue or FCF.
Key Metrics
Revenue Growth TTM19.77%OK
Revenue CAGR 3Y15.35%OK
Gross Margin78.36%OK
Operating Margin17.41%OK
FCF Margin11.23%OK
FCF Growth-20.2%OK
ROIC24.85%OK
Incremental Operating Margin 3Y30.7%OK
Net Debt / CFO-1.94xOK
Diluted Share Growth 1Y-3.41%OK
SBC / Revenue3.88%OK
SBC / FCF34.55%OK
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 FY Jun 30, 2026 | $73.78M | $57.94M | $13.88M | $9.67M | $8.41M | 78.54% | 18.82% | 11.4% | 35.55% | 8.69M |
| 2026 FY Jun 30, 2025 | $64.00M | $49.97M | $9.66M | $11.39M | $11.13M | 78.08% | 15.09% | 17.39% | 25.11% | 8.91M |
| 2025 FY Jun 30, 2024 | $54.72M | $41.73M | $6.58M | $9.07M | $8.78M | 76.26% | 12.03% | 16.05% | 16.4% | 8.86M |
| 2024 FY Jun 30, 2023 | $48.07M | $36.52M | $4.01M | $1.32M | -$333,000.00 | 75.98% | 8.34% | -0.69% | 11.03% | 8.7M |
| 2023 FY Jun 30, 2022 | $41.66M | $31.44M | $2.97M | -$686,000.00 | -$2.11M | 75.47% | 7.13% | -5.07% | 9.81% | 8.77M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $70.04M | sum latest 4 fiscal quarters Revenue | OK | 0001437749-26-016429, 0001437749-25-034445 |
| Revenue Growth TTM | 19.77% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001437749-26-016429, 0001437749-25-034445 |
| Revenue CAGR 3Y | 15.35% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001437749-26-028914 |
| Revenue CAGR 5Y | 15.59% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001437749-26-028914 |
| Gross Profit CAGR 3Y | 16.63% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001437749-26-028914 |
| Operating Income Growth | 42.08% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001437749-26-016429, 0001437749-25-034445 |
| FCF Growth | -20.2% | FCF_current / FCF_prior_year - 1 | OK | 0001437749-26-016429, 0001437749-26-003635 |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 78.36% | Gross Profit / Revenue | OK | 0001437749-26-016429, 0001437749-25-034445 |
| Operating Margin | 17.41% | Operating Income / Revenue | OK | 0001437749-26-016429, 0001437749-25-034445 |
| FCF Margin | 11.23% | (CFO - CapEx) / Revenue | OK | 0001437749-26-016429, 0001437749-26-003635 |
| ROIC | 24.85% | NOPAT / Average Invested Capital | OK | 0001437749-26-016429, 0001437749-25-034445 |
| Net Debt / CFO | -1.94x | Net Debt / CFO | OK | 0001437749-26-016429, 0001437749-26-003635 |
| Current Ratio | 4.91x | Current Assets / Current Liabilities | OK | derived |
| SBC / Revenue | 3.88% | SBC / Revenue | OK | 0001437749-26-016429, 0001437749-26-003635 |